FGFR3 and neoplasm: The striking mononuclear inflammatory reaction in the stromal background and within the tumor cell aggregates in these three tumors might be explained by recent studies which illustrated activation of an inflammatory response pathway resulting from activated FGFR3-MAPK signaling in FGFR3::TACC3 fusion neoplasms [16].